Targeted Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.58M Buy
6,044
+2
+0% +$513 1.16% 15
2026
Q2
$1.52M Buy
6,042
+501
+9% +$108K 1.12% 16
2026
Q1
$1.21M Sell
5,541
-498
-8% -$110K 0.99% 17
2025
Q4
$1.38M Hold
6,039
– – 1.18% 15

Other funds holding ABBV

Targeted Financial Services's ABBV Position: Q3 2026 in Review

Targeted Financial Services increased its AbbVie (ABBV) stake by 0.03% in Q3 2026, buying an estimated $513 and bringing the position to 6,044 shares worth $1.58M. The position accounts for 1.16% of the portfolio, ranked #15.

Targeted Financial Services first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Targeted Financial Services held 6,044 shares of AbbVie worth $1.58M as of Q3 2026.
  • Targeted Financial Services bought 2 AbbVie shares in Q3 2026, an estimated $513.
  • AbbVie made up 1.16% of Targeted Financial Services's portfolio in Q3 2026, its #15 holding.
  • Targeted Financial Services first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Targeted Financial Services's 13F filing for Q3 2026, filed 19 Oct 2026.